Institute for Research in Biomedicine
The change at the helm of the Institute for Research in Biomedicine (IRB, affiliated to USI) has occurred at the end of July, with Prof. Antonio Lanzavecchia succeded by Prof.
on April 3, 2020 When DNA breaks, cells need to join the broken DNA pieces in an accurate way to prevent mutations. Cells utilize the so-called homologous recombination pathway to
on Monday, March 16, 2020 A research team led by the Institute for Research in Biomedicine (IRB) in Bellinzona, affiliated to the Università della Svizzera italiana, has identified a molecular network
on March 12, 2020 Following the publication of a €10 million call in January, the European Commission has secured an additional €37.5 million for urgently needed research on COVID-19 vaccine
Bellinzona, September 7, 2021 – Following the development of a second-generation antibody against the novel coronavirus (SARS-CoV-2) and its variants, the Institute for Research in Biomedicine (IRB, affiliated to USI)
June 28, 2021: The Società degli Accademici italiani in Svizzera (SAIS) awards Italian students that pursued their PhD in Switzerland by offering three prizes for the best doctoral theses, one
June 25, 2021: During the 10° giornata della Ricerca della Svizzera italiana, organized by the EOC Clinical Trial Unit and the Università della Svizzera italiana (USI), held at USI in
On December 15, 2020, during the second IRB Town Hall meeting, Ilaria Ceppi and Giordano Reginato (Recombination Mechanisms Lab) and Tommaso Virgilio (Infection and Immunity Lab) were announced as the
The IRB informs that any press release mentioning the IRB should be reviewed by our media and communication service. Please contact:
Cristina Elia Ott
press@usi.ch
+41 58 666 4792
Via Vincenzo Vela 6
6500 Bellinzona, Switzerland
Tel. +41 91 820 0300
Fax +41 91 820 0302
Facebook / Twitter
